11-1390303-G-A

Variant summary

Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting

The NM_001256627.2(BRSK2):​c.19G>A​(p.Asp7Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000356 in 1,039,550 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000075 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000029 ( 0 hom. )

Consequence

BRSK2
NM_001256627.2 missense

Scores

1
1
16

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 1.72
Variant links:
Genes affected
BRSK2 (HGNC:11405): (BR serine/threonine kinase 2) Enables several functions, including ATP binding activity; ATPase binding activity; and protein kinase activity. Involved in several processes, including cellular protein metabolic process; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; and regulation of insulin secretion involved in cellular response to glucose stimulus. Located in centrosome and endoplasmic reticulum. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.03531742).
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.0000747 (11/147210) while in subpopulation EAS AF= 0.00137 (7/5094). AF 95% confidence interval is 0.000645. There are 0 homozygotes in gnomad4. There are 1 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
BRSK2NM_001256627.2 linkuse as main transcriptc.19G>A p.Asp7Asn missense_variant 1/20 ENST00000528841.6 NP_001243556.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
BRSK2ENST00000528841.6 linkuse as main transcriptc.19G>A p.Asp7Asn missense_variant 1/201 NM_001256627.2 ENSP00000432000 P1Q8IWQ3-1

Frequencies

GnomAD3 genomes
AF:
0.0000748
AC:
11
AN:
147126
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000674
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00137
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00148
GnomAD4 exome
AF:
0.0000291
AC:
26
AN:
892340
Hom.:
0
Cov.:
32
AF XY:
0.0000192
AC XY:
8
AN XY:
416464
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000676
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000633
Gnomad4 OTH exome
AF:
0.000539
GnomAD4 genome
AF:
0.0000747
AC:
11
AN:
147210
Hom.:
0
Cov.:
32
AF XY:
0.0000139
AC XY:
1
AN XY:
71704
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.0000673
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00137
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00146
Bravo
AF:
0.0000680
ExAC
AF:
0.0000193
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsFeb 28, 2023The c.19G>A (p.D7N) alteration is located in exon 1 (coding exon 1) of the BRSK2 gene. This alteration results from a G to A substitution at nucleotide position 19, causing the aspartic acid (D) at amino acid position 7 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
BRSK2-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesAug 18, 2022The BRSK2 c.19G>A variant is predicted to result in the amino acid substitution p.Asp7Asn. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.032% of alleles in individuals of East Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/11-1411533-G-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.17
T
BayesDel_noAF
Benign
-0.48
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Benign
0.10
.;T;.;.
Eigen
Benign
-0.52
Eigen_PC
Benign
-0.42
FATHMM_MKL
Benign
0.70
D
LIST_S2
Benign
0.80
T;T;T;T
M_CAP
Pathogenic
0.50
D
MetaRNN
Benign
0.035
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-1.0
N;N;N;N
MutationTaster
Benign
1.0
N;N;N;N;N
PROVEAN
Benign
0.51
N;N;N;N
REVEL
Benign
0.049
Sift
Benign
0.40
T;T;T;T
Sift4G
Benign
0.48
T;T;T;T
Polyphen
0.13
B;B;B;B
Vest4
0.082
MutPred
0.22
Gain of MoRF binding (P = 0.0319);Gain of MoRF binding (P = 0.0319);Gain of MoRF binding (P = 0.0319);Gain of MoRF binding (P = 0.0319);
MVP
0.52
ClinPred
0.13
T
GERP RS
1.6
Varity_R
0.089

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs533360037; hg19: chr11-1411533; API